Mensing v. Wyeth, Inc.

Core Citations

REVERSED BY OTHER CASE in

• Jacobsen v. Wyeth, LLC
• Richland/Wilkin Joint Powers Auth. v. U.S. Army Corps of Eng'rs
• Aucoin v. Amneal Pharms., LLC

[See more]

• Fullington v. Pfizer, Inc.
• Bell v. Pfizer, Inc.
• In re Zantac (Ranitidine) Prods. Liab. Litig.
• Gardley-Starks v. Pfizer, Inc., Civil Action No. 4:10–CV–099–SA–JMV.
• Schrock v. Wyeth, Inc.
• Cooper v. Wyeth, Inc.
• Morris v. Wyeth, Inc.
• Wyeth. Inc. v. Weeks
• Wyeth, Inc. v. Weeks
• In re Zantac (Ranitidine) Prods. Liab. Litig.
• Strayhorn v. Wyeth Pharms., Inc.
• Strayhorn v. Wyeth Pharm., Inc.
• Huck v. Wyeth, Inc.

This document cites

• Federal Cases - Grand River Enterprises Six Nations, Ltd. v. Beebe
• Federal Cases - Demahy v. Wyeth Inc.
• Federal Cases - Bates v. Dow Agrosciences LLC
• Federal Cases - Foster v. American Home Products Corp.
• Federal Cases - Bartlett v. Mutual Pharmaceutical Co., Inc.



See all quotations

• Minnesota - Flynn v. American Home Products Corp., C8-00-1885.
• Federal Cases - Fidelity Federal Savings and Loan Association v. Cuesta
• Federal Cases - Colacicco v. Apotex Inc.
• Minnesota - Bixler by Bixler v. Avondale Mills
• Federal Cases - Wyeth v. Levine
• Federal Cases - Schrock v. Wyeth, Inc.
• Federal Cases - Crosby v Nat'l Foreign Trade Council
• Federal Cases - Rice v. Norman Williams Company Bohemian Distributing Company v. Norman Williams Company Wine Spirits Wholesalers of California v. Norman Williams Company
• Federal Cases - Mensing v. Wyeth, Inc.
• Federal Cases - Kellogg v. Wyeth, Case No. 2:07-cv-82.
• Federal Cases - Colacicco v. Apotex, Inc.
• Federal Cases - Noble Systems Corp. v. Alorica Central, LLC
• Federal Cases - Stacel v. Teva Pharmaceuticals, Usa
• Federal Cases - Takele v. Mayo Clinic
• Minnesota - Specialized Tours, Inc. v. Hagen
• US - Reference Stubs - Misbranded drugs and devices
• US - Reference Stubs - Withdrawal of approval of an application or abbreviated application
• US - Reference Stubs - Requirements on content and format of labeling for human prescription drug and biological products
• US - Reference Stubs - Supplements and other changes to an approved ANDA
• US - Reference Stubs - Postmarketing reporting of adverse drug experiences
• US - Reference Stubs - Supplements and other changes to an approved NDA
• US - Reference Stubs - Risk evaluation and mitigation strategies
• US - Reference Stubs - New drugs
• US - Reference Stubs - Prohibited acts
• US - Reference Stubs - Postmarketing reports
• US - Reference Stubs - Minn. Stat. § 151.21 Substitution